Nav: Home

Pregnancy-specific β1-glycoproteins

February 27, 2017

Development of new strategies and novel drug design to treat trophoblastic diseases and to provide pregnancy success are of crucial importance in maintenance the female reproductive health. Pregnancy specific β1-glycoproteins (PSGs) have long been recognized as trophoblast quality and embryo viability markers. This review article summarizes and discusses advances in 45-year studies on biological roles of PSGs, and structure/function relationships to other fetoplacental proteins as well as implications for drug design with focus on the latest achievements and the challenges for future investigations. PSGs were first discovered with the use of immunochemical methods by Russian scientists Yuri Tatarinov and Vitaliy Masyukevich in the blood serum of pregnant women as early as in 1970. Later, the same protein was isolated from human placental extracts by German researcher Hans Bohn, and discovered in serum of patients with trophoblastic and testicular tumors by several investigators. Combined concentration measurements of placenta-derived circulating proteins including PSGs, human chorionic gonadotropin (hCG), human placental lactogen (hPL), pregnancy-associated plasma protein A (PAPP-A), and proform of eosinophil major basic protein (proMBP) represent the useful tool for evaluating and monitoring pregnancy success and/or complications such as post-implantation embryo viability, pre-eclampsia, extra-uterine pregnancy, and growth retardation. However, integrated biomarker profiling technologies including genetics, epigenetic, omics, systems biology, bioinformatics and molecular imaging approaches are being developed for novel biomarker discovery to increase sensitivity and specificity of quantitative tests for pregnancy success and trophoblastic diseases. Except the role in early embryo implantation, PSGs have been shown to possess immunomodulatory and anti-inflammatory functions, along with ability to regulate vascular morphogenesis and hemostasis. All these functions are, plausibly, mediated through binding to cell surface receptor(s). However, CD9 cell surface glycoprotein belonging to tetraspanin (transmembrane 4) superfamily has been identified as the receptor for murine PSG17 and PSG19, while proteoglycans have been shown to bind murine PSG17, PSG22, PSG23, and human PSG1.

Additionally, human PSG1 occurs to be able to interact with integrins that are receptors for cell adhesion proteins involved in cell-to-cell or cell-to-extracellular matrix attachment, the process underlying cell migration, proliferation, differentiation, invasion, and apoptosis during embryonic development and carcinogenesis. PSGs belong to carcinoembryonic antigen (CEA) family that, in turn, is a part of immunoglobulin (Ig) superfamily and includes the following two subfamilies: (i) CEA-related adhesion molecules (CEACAMs) and (ii) pregnancy-specific beta-1 glycoproteins (PSGs). Genes of CEA family are clustered on chromosome 19 in the region 19q13.2-19q13.4 in humans, and on chromosome 7 and chromosome 1 in mice and rats, respectively. Ten genes encoding human PSGs (PSG1-PSG9, PSG11) and seventeen genes encoding rodent PSGs (psg16-psg32) have been identified to date. Structurally, PSGs represent highly glycosylated proteins with carbohydrate content from 21 to 32%. Molecular weight of their protein moieties varies from about 37 to 49 kDa in humans and from 44 to 54 kDa in rodents; the net molecular weight of PSGs including carbohydrate moieties may reach up to 72 kDa. Proteins of both subfamilies of CEA family, CEACAMs and PSGs, have been shown to possess similar mosaic multi-domain structure that provides their polyfunctional properties. Both human and rodent PSGs compose of a signal peptide and up to 3 Ig-like V(variable)-type and up to 4 Ig-like C(constant)-type domains. The Ig-like V-type domain is characteristic for all proteins of CEA family suggesting their common functions. Another type of structural modules in PSGs are short linear motifs (SLiMs) that represent amino acid sequences typically of 3 to 10 residues in length. Among the SLiMs found in PSGs are integrin-binding RGD tripeptide and proline-rich PxxP motif involved in protein-protein interactions as the site for a protein binding to SH3-domains of various signaling molecules, protein kinases and adaptor proteins. Additionally, in the all human PSGs and in part of rodent PSGs we found YxCx motifs that resemble the part of human alpha-fetoprotein (AFP)-derived biologically active peptide. Biological activities of PSG-derived tetrapeptides (YECE, YVCE, YACS, and YACE), along with CEA-derived pentapeptide (SYKCE) and AFP-derived LDSYQCT heptapeptide were studied by our group in the test of cluster of differentiation (CD) antigen expression by B and T-lymphocytes. We found that the YECE peptide was the most capable in decreasing the expression of CD25, CD71 and HLA-DR antigens by T-lymphocytes from patients with rheumatoid arthritis as compared to healthy donors. Additionally, this peptide stimulated the expression of apoptosis-inducing receptor CD95 and its ligand, CD95L, while other peptides had no effects on their expression. We consider all these short peptides derived from fetoplacental proteins such as AFP, PSGs, CEA, and hCG to serve as a basis to design novel peptide-mimetic therapeutic agents to be used in treatment of cancer, immunologic, allergic and infectious diseases, and pregnancy disorders.
For more information about the article, please visit:

Reference: Moldogazieva, NT.; (2017). Pregnancy-Specific β1-Glycoproteins: Combined Biomarker Roles, Structure/Function Relationships and Implications for Drug Design. Current Medicinal Chemistry., DOI: 10.2174/0929867324666161123090554

Bentham Science Publishers

Related Pregnancy Articles:

Paracetamol during pregnancy can inhibit masculinity
Paracetamol during pregnancy can inhibit masculinity Paracetamol during pregnancy can inhibit the development of 'male behavior' in mice.
The cost of opioid use during pregnancy
A new study published today by the scientific journal Addiction reveals that the incidence of neonatal abstinence syndrome -- often caused by mothers using opioids during pregnancy -- is increasing in the United States, and carries an enormous burden in terms of hospital days and costs.
New study: Pre-pregnancy BMI directly linked to excess pregnancy weight gain
It's well known that excessive weight gain during pregnancy can have a lasting negative impact on the health of a mother and her baby.
Pregnancy-specific β1-glycoproteins
Development of new strategies and novel drug design to treat trophoblastic diseases and to provide pregnancy success are of crucial importance in maintenance the female reproductive health.
Should hypothyroidism in pregnancy be treated?
When a woman becomes pregnant, many changes occur in her body.
Pre-pregnancy progesterone helps women with recurrent pregnancy loss
Women who have had two or more unexplained miscarriages can benefit from natural progesterone treatment before pregnancy, a new a study from the University of Illinois at Chicago shows.
Male pipefish pregnancy, it's complicated
In the upside-down world of the pipefish, sexual selection appears to work in reverse, with flashy females battling for males who bear the pregnancy and carry their young to term in their brood pouch.
Pregnancy leads to changes in the mother's brain
A study directed by researchers from the UAB and IMIM are the first to reveal how pregnancy causes long-lasting alterations in brain structure, probably related to improving the mother's ability to protect and interact with the child.
MRIs during pregnancy and outcomes for infants, children
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the Sept.
The benefits of exercise during pregnancy
Women who exercise during pregnancy are more likely to deliver vaginally than those who do not, and show no greater risk of preterm birth.

Related Pregnancy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...